G Gopinathan

437 total citations
18 papers, 305 citations indexed

About

G Gopinathan is a scholar working on Neurology, Organic Chemistry and Genetics. According to data from OpenAlex, G Gopinathan has authored 18 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Neurology, 5 papers in Organic Chemistry and 3 papers in Genetics. Recurrent topics in G Gopinathan's work include Parkinson's Disease Mechanisms and Treatments (10 papers), Neurological disorders and treatments (4 papers) and Parkinson's Disease and Spinal Disorders (4 papers). G Gopinathan is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (10 papers), Neurological disorders and treatments (4 papers) and Parkinson's Disease and Spinal Disorders (4 papers). G Gopinathan collaborates with scholars based in United States, India and Canada. G Gopinathan's co-authors include James M. Dambrosia, Andreas Neophytides, Morton Leibowitz, Vincent B. Ho, Marc Z. Handler, Irvin I. Kricheff, L Laubenstein, D. B. Calne, Jerome N. Sanes and Christopher D. Ward and has published in prestigious journals such as Neurology, Radiology and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

G Gopinathan

17 papers receiving 283 citations

Peers

G Gopinathan
Kun Hong China
Shavonne Teng United States
Michelle Onorato United States
Sophie Calvert Australia
Susan A. Queen United States
G Gopinathan
Citations per year, relative to G Gopinathan G Gopinathan (= 1×) peers Federico Angelo Cazzaniga

Countries citing papers authored by G Gopinathan

Since Specialization
Citations

This map shows the geographic impact of G Gopinathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Gopinathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Gopinathan more than expected).

Fields of papers citing papers by G Gopinathan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Gopinathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Gopinathan. The network helps show where G Gopinathan may publish in the future.

Co-authorship network of co-authors of G Gopinathan

This figure shows the co-authorship network connecting the top 25 collaborators of G Gopinathan. A scholar is included among the top collaborators of G Gopinathan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Gopinathan. G Gopinathan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Gopinathan, G, et al.. (2024). Rapid improvement of oculomotor nerve function with ayurvedic treatment in traumatic diplopia - A case report. Journal of Ayurveda and Integrative Medicine. 15(2). 100889–100889.
2.
Rajagopala, Manjusha & G Gopinathan. (2015). Ayurvedic management of papilledema. AYU (An International Quarterly Journal of Research in Ayurveda). 36(2). 177–177. 3 indexed citations
3.
Gopinathan, G, et al.. (1990). Mesulergine: a dopamine agonist with novel properties in Parkinson's disease.. PubMed. 53. 533–7. 1 indexed citations
4.
Lieberman, A., G Gopinathan, Andreas Neophytides, Peter F. Pasternack, & M. Goldstein. (1987). Advanced Parkinson's disease. Neurology. 37(5). 863–863. 4 indexed citations
5.
Burns, Richard S., G Gopinathan, M. Hümpel, R. Dorow, & Donald B. Calne. (1984). Disposition of oral lisuride in parkinson's disease. Clinical Pharmacology & Therapeutics. 35(4). 548–556. 9 indexed citations
6.
Gopinathan, G, et al.. (1984). Pergolide and lisuride in advanced Parkinson's disease.. PubMed. 40. 503–7. 8 indexed citations
7.
Lieberman, Abraham, G Gopinathan, Andreas Neophytides, et al.. (1984). DOPAMINE AGONISTS IN PARKINSONʼS DISEASE. Clinical Neuropharmacology. 7. S509–S509. 5 indexed citations
8.
Gopinathan, G, Andreas Neophytides, Emile Hiesiger, et al.. (1984). Deprenyl in the treatment of Parkinson's disease. A specific type B monoamine oxidase inhibitor.. PubMed. 84(1). 13–6. 9 indexed citations
9.
Lieberman, A N, et al.. (1983). Comparative efficacy of pergolide and bromocriptine in patients with advanced Parkinson's disease.. PubMed. 37. 95–108. 34 indexed citations
10.
Kricheff, Irvin I., et al.. (1983). Acquired immunodeficiency syndrome: cerebral computed tomographic manifestations.. Radiology. 149(2). 477–484. 74 indexed citations
11.
Leibowitz, Morton, et al.. (1983). The effects of pergolide on the cardiovascular system of 40 patients with Parkinson's disease.. PubMed. 37. 121–30. 8 indexed citations
12.
LeWitt, P., G Gopinathan, Christopher D. Ward, et al.. (1982). Lisuride versus bromocriptine treatment in Parkinson disease. Neurology. 32(1). 69–69. 37 indexed citations
13.
Neophytides, Andreas, A N Lieberman, Menek Goldstein, et al.. (1982). The use of lisuride, a potent dopamine and serotonin agonist, in the treatment of progressive supranuclear palsy.. Journal of Neurology Neurosurgery & Psychiatry. 45(3). 261–263. 23 indexed citations
14.
Gopinathan, G, H. Teräväinen, James M. Dambrosia, et al.. (1981). Lisuride in parkinsonism. Neurology. 31(4). 371–371. 40 indexed citations
15.
Gopinathan, G, et al.. (1981). Lisuride in parkinsonism. Neurology. 31(4_part_2). 371–376. 25 indexed citations
16.
Eisler, Toomas, et al.. (1980). Progress in the pharmacotherapy of Parkinsonism.. PubMed. 23. 237–43. 2 indexed citations
17.
Lieberman, A., et al.. (1980). Evaluation of Parkinson's disease.. PubMed. 23. 277–86. 20 indexed citations
18.
Lieberman, A N, Mark J. Kupersmith, Andreas Neophytides, et al.. (1980). Bromocriptine in Parkinson's disease: report on 106 patients treated for up to 5 years.. PubMed. 23. 245–53. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026